1. Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
- Author
-
Gardner LS, Vaughan L, Avery DT, Meyts I, Ma CS, Tangye SG, Varikatt W, and Lin MW
- Subjects
- Humans, Intercellular Signaling Peptides and Proteins deficiency, Intercellular Signaling Peptides and Proteins genetics, Male, Female, Hereditary Autoinflammatory Diseases, Lymphoma, Large B-Cell, Diffuse etiology, Lymphoma, Large B-Cell, Diffuse diagnosis, Lymphoma, Large B-Cell, Diffuse genetics, Epstein-Barr Virus Infections complications, Epstein-Barr Virus Infections diagnosis, Adenosine Deaminase deficiency, Adenosine Deaminase genetics, Herpesvirus 4, Human
- Abstract
Deficiency of Adenosine Deaminase 2 (DADA2) patients presenting with primary immunodeficiency are at risk of uncontrolled EBV infection and secondary malignancies including EBV-related lymphoproliferative disorders (LPD). This paper describes the first case of EBV related diffuse large B-cell lymphoma in a patient with DADA2 and uncontrolled EBV infection. Consideration should be given to monitoring for EBV viraemia and to preventative EBV specific therapy in DADA2 and patients with at risk primary immunodeficiencies. A type I interferon (IFN) gene signature is associated with DADA2 though its association with immune dysregulation is unclear., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF